测定髓过氧化酶（MPO）活性，反映PVEC粘附PMN的数量。
The myeloperoxidase (MPO) was also assayed to reflect the magnitude of PVEC-PMN adhesion.
方法将急性冠状动脉综合征患者随机分为普罗布考组和对照组，分别检测治疗前后血清髓过氧化酶和高敏C反应蛋白的浓度。
Methods: 154 patients with ACS were randomly separated into Probiacol treatment group and control group. The serum concentration of MPO and hs-CRP was measured before and after treatment.
观察血浆丙二醛（MDA）、超氧化物歧化酶（SOD）及组织中丙二醛和髓过氧化酶（MPO）的含量变化，并观察小肠、肝、肺的病理变化。
The concentration of malondialdehyde(MDA), superoxide dismutase (SOD) and myeloperoxidase (MPO) in plasma and in liver, kidney and intestine were determined at different times in all groups.
观察血浆丙二醛（MDA）、超氧化物歧化酶（SOD）及组织中丙二醛和髓过氧化酶（MPO）的含量变化，并观察小肠、肝、肺的病理变化。
The concentration of malondialdehyde(MDA), superoxide dismutase (SOD) and myeloperoxidase (MPO) in plasma and in liver, kidney and intestine were determined at different times in all groups.
应用推荐